QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2017     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A phase III trial (ZJBIO009): CMAB009 plus irinotecan versus irinotecan alone as second-line treatment after fluoropyrimidine and oxaliplatin failure in wild-type K-ras metastatic colorectal cancer patients 期刊论文 Journal of Clinical Oncology, 2017, 卷号: 35 作者:  Shi Y., Li J., Xu J., Cheng Y., Liu W., Cheng Y., Bai L., Zhang Y., He X., Luo Y., Liu Y., Yao Q., Li Y., Qin S., Hu X., Guo Y., Sun Y. 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 Self-Assembly of an Amphiphilic Janus Camptothecin-Floxuridine Conjugate into Liposome-Like Nanocapsules for More Efficacious Combination Chemotherapy in Cancer 期刊论文 ADVANCED MATERIALS, 2017 Liang, Xiaolong; Gao, Chuang; Cui, Ligang; Wang, Shumin; Wang, Jinrui; Dai, Zhifei 收藏  |  浏览/下载：6/0  |  提交时间：2017/12/03 cancer chemotherapy  coordinated release  drug-drug conjugates  Janus nanoparticles  self-assembly  STEALTH LIPOSOMES  DRUG-DELIVERY  IN-VIVO  THERAPY  TUMOR  NANOPARTICLES  IRINOTECAN  NANODRUG  RATIOS   A phase III trial (ZJBI0009): CMABOO9 plus irinotecan versus irinotecan alone as second-line treatment after fluoropyrimidine and oxaliplatin failure in wild-type K-ras metastatic colorectal cancer patients. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20 作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Cheng, Ying;  Liu, Wei 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 A phase III trial (ZJBI0009): CMABOO9 plus irinotecan versus irinotecan alone as second-line treatment after fluoropyrimidine and oxaliplatin failure in wild-type K-ras metastatic colorectal cancer patients. 期刊论文 2017, 卷号: 35 作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Cheng, Ying;  Liu, Wei 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04